The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > REGULATORY
REGULATORY
- Chuikyo Rep Nakagawa Casts Doubt on 80% Generic Target
August 28, 2015
- MHLW Panel Recommends Creation of Database on Rare Cancers by Type
August 28, 2015
- MHLW Mulls Ordering Pfizer to Improve Biz Operations over ADR Reporting
August 28, 2015
- Panel OKs Medical Subsidy for Harvoni, Monthly Copay Up to 20,000 Yen
August 28, 2015
- Commentary: Spiking Drug Prices Behind Harvoni Pricing Spat at Chuikyo
August 28, 2015
- PFSB to Monitor Drug Companies’ Promotional Activities at 20 Selected Medical Facilities
August 28, 2015
- PFSB to Request Budget of 10.7 Billion Yen in FY2016 to Improve Environments for Development of Innovative Drugs, Quality of Generics
August 28, 2015
- Health Service Bureau Seeks 469.1 Billion Yen in FY2016 Budget, 120.2 Billion Yen for Intractable Diseases
August 28, 2015
- Health Policy Bureau Seeks 193.6 Billion Yen in FY2016 Budget, 6.6 Billion Yen for Clinical Research Promotion
August 28, 2015
- FPMAJ Wants Continuation of Innovation Premium, No Market Price-Based Price Revision in 2017: Chuikyo Hearings
August 27, 2015
- Chuikyo’s HTA Panel Issues Interim Report, Appraisal Results to Be Used to Re-Price Selected Listed Drugs
August 27, 2015
- Development Projects, Regulatory Filings Increasing Thanks to Innovation Premium: PhRMA, EFPIA
August 27, 2015
- MHLW Seeks 30.7 Trillion Yen in FY2016 Budget, 104.3 Billion for Drug, Healthcare Initiatives
August 27, 2015
- Chuikyo Reps Trade Barbs over Pricing of Harvoni, Listing OK'ed by a Whisker
August 27, 2015
- Chuikyo OKs Listing of Harvoni, Peak Sales Put at 119 Billion Yen in 2nd Year
August 26, 2015
- 4 Pharma Groups Welcome MHLW’s “Comprehensive Strategy”
August 25, 2015
- MHLW OKs New Indications for Remicade, Other Products
August 25, 2015
- MHLW Reveals Outline of “Comprehensive Strategy” for Pharma Sector
August 25, 2015
- Drug Pricing Tomorrow: MHLW Councilor Takeda Says NHI Drug Prices Should Mirror Evaluation of Individual Firms
August 24, 2015
- Editor’s Pick: Five Healthcare News Headlines for August 10 - August 23
August 24, 2015
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…